CS
QTTB icon

Credit Suisse’s Q32 Bio QTTB Stock Holding History

Credit Suisse’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,413
Closed -$77K – 4378
2022
Q1 		$77K Sell
1,413
-48
-3% -$2.98K ﹤0.01% 3491
2021
Q4 		$96K Buy
1,461
+69
+5% +$6.7K ﹤0.01% 4384
2021
Q3 		$196K Buy
1,392
+153
+12% +$19.5K ﹤0.01% 4237
2021
Q2 		$161K Buy
1,239
+420
+51% +$52.4K ﹤0.01% 4315
2021
Q1 		$139K Sell
819
-564
-41% -$119K ﹤0.01% 4166
2020
Q4 		$281K Buy
1,383
+583
+73% +$113K ﹤0.01% 4007
2020
Q3 		$153K Sell
800
-1,952
-71% -$437K ﹤0.01% 3884
2020
Q2 		$752K Buy
2,752
+2,187
+387% +$583K ﹤0.01% 3085
2020
Q1 		$158K Sell
565
-23
-4% -$7.04K ﹤0.01% 3721
2019
Q4 		$219K Sell
588
-7,934
-93% -$2.27M ﹤0.01% 3953
2019
Q3 		$2.78M Buy
8,522
+7,518
+749% +$2.56M ﹤0.01% 2224
2019
Q2 		$353K Sell
1,004
-294
-23% -$116K ﹤0.01% 3598
2019
Q1 		$648K Buy
1,298
+408
+46% +$182K ﹤0.01% 3197
2018
Q4 		$358K Buy
+890
New +$337K ﹤0.01% 3435

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse's QTTB Position: Q2 2022 in Review

Credit Suisse sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 1,413 shares — an estimated $77K sold.

Credit Suisse first reported a position in QTTB in Q4 2018 and held it in 14 quarters. The position peaked at $2.78M in Q3 2019. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • Credit Suisse reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • Credit Suisse sold 1,413 Q32 Bio shares in Q2 2022, an estimated $77K.
  • Credit Suisse first reported a position in Q32 Bio in Q4 2018 and held it in 14 quarters.
  • Credit Suisse's Q32 Bio position peaked at $2.78M in Q3 2019.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.